Creating next generation gene therapies for blindness.
Our Mission
Our mission is to develop innovative gene therapies for retinal diseases, including rare ophthalmic conditions that have a profound impact on quality of life.
What We Do
We leverage our computationally guided scAAVengr platform to generate and validate a toolkit of proprietary AAV vectors.
What Makes Us Different
Our quantitative, in vivo-based approach and clinical ophthalmology expertise allow us to rapidly translate new gene therapies to the clinic.
CAREERS
At Avista Therapeutics, we are always on the lookout for talented individuals who share in our passion to create next generation gene therapies for currently untreatable retinal diseases.
Please contact us for more information on career opportunities: info@avistatx.com
NEWS
Avista Therapeutics Partners with Roche to Develop Next-Generation AAV Gene Therapy Vectors for Ocular Diseases